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Abstract
In 2012, medical regulation in the United Kingdom was fundamentally changed by the introduction of revalidation – a process
by which all licensed doctors are required to regularly demonstrate that they are up to date and fit to practice in their chosen
field and are able to provide a good level of care. This paper examines the implications of revalidation on the structure, gover-
nance, and performance management of the medical profession, as well as how it has changed the relationships between the
regulator, employer organizations, and the profession. We conducted semi-structured interviews with clinical and non-clinical
staff from a range of healthcare organizations. Our research suggests that organizations have become intermediaries in the
relationship between the General Medical Council and doctors, enacting regulatory processes on its behalf and extending regu-
latory surveillance and oversight at local level. Doctors’ autonomy has been reduced as they have become more accountable to
and reliant on the organizations that employ them.
Keywords: accountability, health services, medicine, professionalism, regulatory governance.
1. Introduction
The organization and management of medical work has long attracted considerable attention among academics
and healthcare policymakers alike. Much of this work has focused around the concept of professionalism and
autonomy (Kuhlmann & Burau 2008; Rees 2008; Exworthy 2015). Research specifically considering the regulation
of medical work is less common. Such research has focused on how changes to regulation have been responded
to by the medical profession, and what this means for the profession’s relationship with the regulator, govern-
ment, and wider society (Trubek et al. 2008; Waring et al. 2010; Chamberlain 2014; Archer et al. 2017).
Medical regulation in the United Kingdom (UK) was fundamentally changed in 2012 with the introduction
of revalidation – a continued competency process by which “all licensed doctors are required to demonstrate on
a regular basis that they are up to date and fit to practice in their chosen field and able to provide a good level of
care” (General Medical Council [GMC] 2013). Before revalidation was introduced, once doctors qualified and
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joined the medical register they were only subject to regulatory scrutiny if concerns were raised with the regulator
by patients, colleagues, employers, or others about their performance and fitness to practice. The introduction of
medical revalidation followed more than a decade of protracted debate between the regulator, government, the
Department of Health, and the profession concerning the regulation of the profession and appropriate methods
for assuring the quality and safety of medical practice (Irvine 2003; Archer et al. 2015). In common with other
such “continued competency” systems internationally (Horsley et al. 2016), revalidation has brought an extension
of regulatory oversight of doctors’ practice throughout their post-qualification careers. To date, most published
work on revalidation has focused on the views and experiences of doctors engaged in the process (UMbRELLA
2016), often explored within particular specialty groups (Dale et al. 2016; Royal College of General Practitioners
2016; Stern 2016; Williams et al. 2016; Morris & Withnall 2017), on its impacts on intra-professional relations
(Chamberlain 2012), and on the profession’s relationship with the medical professional regulator, the General
Medical Council (GMC). However, focusing exclusively on the professional impacts of the introduction and
implementation of revalidation neglects an important dimension of the policy, which sets it apart from past med-
ical regulatory schemes. For the first time, revalidation has brought professional regulatory activity and oversight
formally into the organizational sphere, placing statutory responsibility on organizations for the doctors they
employ, and providing considerable legal powers and duties (GMC 2013). In this paper we consider how the
implementation of revalidation has changed relationships between medical professionals, the organizations they
work in and the statutory professional regulatory body. We begin by providing some background information on
recent regulatory change in the UK medical profession, including revalidation, and set these in the context of rel-
evant theoretical literature. We then detail our methodological approach, set out our findings, and discuss their
implications for the relationships between professional and organizational regulation.
1.1. Background
Revalidation has been implemented against a complex backdrop of existing relationships: those between doctors
as professionals and the institutions within which they undertake their work; and between doctors as profes-
sionals and their professional regulator; as well as the historically less well developed relationship between health-
care organizations and the professional regulator. It can be seen as part of an ongoing move of governance
“upstream” (away from the regulator), with the aim of producing earlier, local resolution for performance con-
cerns and more active and ongoing local oversight of performance. The purposes of revalidation have been much
contested, with some regarding it as an important mechanism to protect patients and improve the quality of care
and others regarding it as an unwelcome and bureaucratic system to exert greater control over doctors with few
real benefits (Archer et al. 2015; Tazzyman et al. 2017). This move brings the work of regulation into the organi-
zational sphere, a situation in which complex relational and governance issues already exist. In order to locate
our analysis within these varied dynamics, it is important to first consider how these relationships have developed
to date.
The GMC traces its history back to the 1858 Medical Act (21 & 22 Vict c 90). Importantly, this direct rela-
tionship between individual professionals and a professional regulatory body was established long before the crea-
tion of the National Health Service (NHS) in the UK, and was founded on a model of medicine that saw doctors
practising autonomously – both in general practice and in hospital medicine. Historically, such autonomy was
seen as a defining characteristic of professional work (Durkheim 1957; Freidson 2001).
However, during the 20th century, as health care provision expanded in scope and became increasingly com-
plex/specialist, doctors were brought into ever closer employment relationships with provider organizations. In
the UK, state provided health care in the form of the NHS particularly exemplified this shift, although indepen-
dent provision continued alongside the new state service. Despite such changes, the management of poor perfor-
mance was still not usually dealt with through formal professional regulatory or disciplinary mechanisms but
instead locally and informally, meaning that doctors still retained considerable autonomy (Rosenthal 1995; Salter
2001; Chamberlain 2009).
More recently, doctors’ influence within healthcare management and autonomy within their own practice has
been seen by many as having declined as a result of a wider societal shift from trusting professions and institu-
tions to holding them to account (Power 1997). Governance was brought increasingly into the organizational
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sphere. Changes included an extension of clinical governance processes driven by central government, with
healthcare organizations required to monitor clinical performance, and an increased role for non-medical man-
agers in health care (Wright 2009; Waring et al. 2010). There was also an increased focus on transparency and
accountability of health care, including medical practice. In addition, reforms to public services involving market-
ization, competition, and increased internal and external accountability, often termed New Public Management,
are argued to have contributed to this trend (Waring et al. 2010).
Regulatory arrangements for medical practice remained, however, largely unchanged, with the GMC responsi-
ble for professional regulation, assuring standards of medical education, and regulating post-qualification doctors’
practice and behaviour through its Fitness to Practice procedures in instances of alleged wrong-doing
(Chamberlain 2014). Beyond this, doctors were expected to be either self-regulating – practising in line with a
shared understanding of professional standards, resolving any transgressions within the profession and often
informally – or were subject to the “three wise [men] procedure,” in which senior doctors would act as an investi-
gating committee (Rosenthal 1995). The regulation of doctors in this manner was increasingly challenged, and a
contentious and, at times, confrontational debate about medical regulatory reform ensued (Irvine 2006; Saks
2014; Adams 2017). A series of high profile medical scandals and resulting public inquiry reports, most notably
the Shipman and Bristol cases, called for change and criticized the GMC for prioritizing the protection of doctors
over patient safety, and for failings in the way in which fitness to practice cases were dealt with (Kennedy 2001;
Smith 2005). In response to the Bristol inquiry report (Smith 2005), the government created a new statutory
body, the Council for Healthcare Regulatory Excellence, to oversee the performance of all health profession regu-
lators, including the GMC, giving it legal powers to challenge fitness to practice decisions it deemed unduly
lenient in court and to audit fitness to practice processes (Professional Standards Authority 2016). The gover-
nance of the GMC was reformed, reducing its council in size and making both professional and lay members
appointed (rather than elected by the membership). New arrangements for independent adjudication and other
changes to fitness to practice proceedings were also introduced (Donaldson 2006; Department of Health 2007).
Importantly, the legislation enabled the introduction of medical revalidation, the last but biggest piece in the jig-
saw of regulatory change.
Revalidation thus forms part of the wider reforms of the regulation of the medical profession (Hasselbalch
2015). The implementation of revalidation was the subject of long negotiations between the GMC, Department of
Health, and professional bodies (Archer et al. 2015). Revalidation fundamentally changed how doctors were regu-
lated by making the regulator–doctor relationship a continuing one throughout a doctor’s medical career and
bringing all practising doctors into that relationship, not only those the subject of complaints or concerns. More-
over, revalidation brought professional regulation into the organizational sphere, moving the governance of doc-
tors upstream to be dealt with earlier and more locally in healthcare organizations. As such, revalidation has
decisively engaged healthcare organizations in regulatory activities in a new way and in turn sought to reduce the
volume of governance issues that are brought to the GMC. Revalidation, in repositioning where regulatory prac-
tices occur, means that such activities now take place in contexts in which complex and varied managerial and
governance issues and systems exist.
The boundary between the medical profession and the organizations in which they are employed is not
straightforward, and doctors both individually and collectively can be construed as acting on behalf of their pro-
fession, their organization, or both. An increasing stratification of the profession has been noted (Freidson 2001;
Waring 2014), with the emergence of professional elites who exercise or enact governance on behalf of the profes-
sion, the regulator, and of organizations or institutions. Arguably, revalidation reinforces such stratification and
extends the reach and intensity of organizational oversight (Bryce et al. 2018). Previous research on regulation
and the medical profession has extensively theorized ongoing reforms, giving particular focus to what they mean
for the relationship between the profession and the regulator and/or state. Reduction in self-regulation and auton-
omy, for example, has been understood by some as a form of deprofessionalization (Schlesinger 2002; Bezes et al.
2012). This interpretation, however, has faced criticism for oversimplifying change, focusing solely on what the
profession was seen to lose, and positioning those within it as both passive agents and in opposition to all man-
agerialism (Harrison & Ahmad 2000). In contrast, restratification theory (Freidson 1985, 1994, 2001) situates the
profession as active in response to ongoing changes (Kirkpatrick et al. 2005). From a restratification perspective,
the profession responds to increased management by restructuring itself in order to maintain autonomy at a
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collective level, establishing new elite groups to deliver oversight and act as mediators between the profession and
the state and regulator. In the development of this argument, a need to critique the extent to which professions
are understood to be able to restratify was raised (Coburn et al. 1997; Waring 2014). Consideration of how much
control the profession has over not only the content but also the context of medicine and whether organizations
(such as the GMC) are co-opted for governmental agendas was argued for.
The Foucauldian concept of governmentality (Foucault 1977, 1991) has been utilized to help understand such
changes to regulation and governance of the medical profession (Waring 2007, 2014; Chamberlain 2012). Gov-
ernmentality proposes that state regulation does not necessarily bring about conformity through explicit direction
and enforcement, but rather through normalization and categorization (Foucault 1977, 1991). By enacting the
requirements and expectations of external regulation (such as appraisal or collection of supporting information
about performance in the case of revalidation), internalization can occur. As a result of this internalized self-regu-
lation, governance from state level is achieved with the reduced need for external oversight (Exworthy 2015).
Analysis from a governmentality perspective enables the exploration of the contours of power within reforms,
which is particularly useful when looking at the renegotiation of professional space, as in this paper (Doolin
2002). From this perspective, power is conceptualized as a system of relationships woven throughout society and
it is within the “place” of the individual that power is enacted. Power is thus understood as a relation or interac-
tion in which people are positioned (Foucault 1977), rather than something possessed. Understanding power as
something constantly under negotiation allows not only for changes in the location of power to be identified but
also for the ongoing relational work of power negotiations to be explored and existing explanations of the profes-
sion’s response to regulation change to be considered. Governmentality thus enables an understanding of the sig-
nificance of changing accountabilities between those involved in the regulatory relationship and the exploration
of these changes as power negotiations.
1.2. How revalidation works
Revalidation is carried out in a five yearly cycle, informed by doctors’ participation in annual appraisals. For most
doctors, appraisals are organized and conducted within an organizational structure, with the appraiser and
appraisal meeting being supplied by the organization with whom the doctor is contracted (in the case of primary
care physicians), or by which they are employed (for those in secondary care). This, along with the requirement
that doctors collect supporting information about their practice to be reviewed at appraisal, which is often col-
lected by the organization and supplied to the doctor for their appraisal, gives healthcare organizations an impor-
tant role within revalidation. Indeed, all organizations employing or contracting doctors (termed “designated
bodies” in the language of the legislation) are required by legislation to appoint a senior doctor to act as Respon-
sible Officer (RO) who must ensure that the organization provides a suitable appraisal process, and who is
charged with monitoring the fitness to practice of all doctors within their organization alongside wider clinical
governance responsibilities (Medical Profession (Responsible Officers) Regulations 2010; GMC 2018). The RO
role is a hybrid position; ROs are themselves members of the medical profession and a manager of other doctors,
in a position that combines responsibility to the employing organization and to the professional regulator (Bryce
et al. 2018). These responsibilities are summarized in Table 1.
Revalidation, then, places requirements not only on individual doctors, but also on the organizations within
which they work. The regulation and governance of organizations is not within the GMC’s statutory remit, but,
as many of revalidation’s component mechanisms draw on organizational data systems and processes, such as
appraisal, the introduction of this professional regulatory intervention has required actions and resources at orga-
nizational level. Organizations with designated body status have been given new responsibilities and obligations
to their doctors’ as a result of the non-negotiable requirements of revalidation (Table 1). In doing so, it divides
responsibility for overseeing medical performance between the medical regulator and organizations. While the
core relationship focused on by revalidation is that between an individual doctor and their professional regulator,
the tripartite distribution of responsibilities inevitably brings organizations into the dynamic. Healthcare organi-
zations – especially those within the NHS – can be seen as part of the state apparatus and acting as a conduit of
state power and policy. They do, however, have some degree of agency as to how to apply that power and meet
their obligations to the state (Hoque et al. 2004). Exploring the role played by organizations in shaping the
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implementation of revalidation is therefore key to understanding this new regulatory landscape. Governmentality
has been chosen as the theoretical perspective because it goes beyond examining the formal structures of the state
to examine how the power of the state can be exerted through a range of organizations in the context of health
care, and offers a fresh perspective on this topic.
This paper sets out to answer two key questions. Firstly, what are the implications of revalidation on the structure,
governance, performance management, and oversight of the medical profession? Secondly, how has revalidation chan-
ged the triumvirate relationship between the regulator, employer organizations, and the medical profession? The Fou-
cauldian concept of governmentality is used as a starting perspective to answer these questions (Foucault 1977, 1991).
2. Method
2.1. Sample
This paper draws on qualitative data collected as part of a wider study to investigate the implementation of medi-
cal revalidation and its impacts on and for healthcare organizations. Healthcare organizations were recruited fol-
lowing a national survey of ROs (Walshe et al. 2017). Using this information, 15 healthcare organizations were
recruited in order to ensure coverage across types, settings, performance (appraisal rates, self-assessment), and
geographic regions. In each organization, procedures, board reports, and role descriptions relating to revalidation
or the management of medical work more broadly were reviewed. We used this information to develop an initial
understanding of the organization’s structure and to inform a list of potential interviewees focusing on those in
key roles relating to revalidation, managing medical work and doctor’s performance, appraisal, and wider gover-
nance and quality and safety processes. In all, we conducted 80 interviews with 79 participants. Healthcare orga-
nization and participant details are listed in Table 2.
Table 1 Responsibilities for revalidation
Doctor Organization/ Designated Body GMC
Licensed doctors who are not trainees
must:
• Have a connection to one organization
(known as a designated body), a Suitable
Person or carry out an annual return
directly to the GMC
• Take part in regular appraisal




 Review of complaints and
complements
 Quality improvement activity
 Feedback from colleagues
 Feedback from patients
• Reflect on supporting information
Organizations are required by the
GMC to provide:
• An RO – new role, responsible
for the revalidation
recommendation
• An up-to-date appraisal system
and ensure every licensed
doctor has a regular appraisal
• A sufficient number of trained
appraisers
• Clinical governance systems that
can provide supporting
information
• Policies and systems for
identifying and responding to
concerns about doctors
• Link with other organizations
where doctors work, so
information about their practice
can be shared




• Deferral (request for GMC to
provide more time for
revalidation decision); does not
affect licence to practice
• Non-engagement (can lose
licence)
As the regulator, the GMC is responsible
for:
• Setting guidelines
• Making the final revalidation decision
based on RO’s recommendation
(to revalidate; how much time to
provide for deferral and whether to
refer to a Fitness to Practice Panel)
• Provide an Employer Liaison Service to
help ROs with revalidation and the
management of concerns about
doctors
CPD, Continued Professional Development; GMC, General Medical Council; RO, Responsible Officer.
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2.2. Data collection
Seven researchers conducted interviews between 2015 and 2017. The research team developed an initial interview
guide based on knowledge gained from reviewing organizations’ documents and literature on the management of
medical performance. Having conducted initial analysis on the first batch of data, we developed a second inter-
view guide to further explore emerging themes and to purposefully focus on filling gaps in the data to reach a
point of apparent data saturation (Green & Thorogood 2013). Interviews were conducted either in person or by
Table 2 Healthcare organizations and participant details
Healthcare organizations by type Participant roles















Director of professional practice,
safety and quality
Mental health charity Appraiser x2
Senior HR business partner
Responsible officer†




Revalidation support officer and HR
business partner
AMD for medical training, education,
and medical regulation
NHS acute hospital and community
health care foundation trust
Previous AMD
AMD x2 (patient safety; revalidation)
Revalidation administrator
Responsible officer and medical
director
NHS acute hospital foundation trust
(medium)
Responsible officer
AMD and deputy responsible officer
Head of clinical governance
Revalidation manager
Head of clinical effectiveness
NHS mental health foundation trusts A
and B











NHS England area teams A and B
(primary care)
Head of inspection – CQC









Assistant director fitness to practice
Practice manager




GP appraisal and revalidation
manager
Private healthcare provider Responsible officer
National director of clinical services
Medical director
Consultant liaison and revalidation
manager
Clinical governance director
Small hospice charity Responsible officer
†Interviewed twice. AMD, Associate Medical Director; CEO, Chief Executive Officer; CIC, Community Integrated Care; CQC,
Care Quality Commission; GP, general practitioner; HR, human resources; LMC, Local Medical Committee; NHS, National
Health Service; PA, personal assistant.
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telephone, according to the preference of the interviewees, and digitally recorded and professionally transcribed
for analysis.
Ethical approval for this study was awarded by the University of Manchester ethics committee (REC 15028).
2.3. Analysis
We imported transcribed data into Dedoose qualitative data analysis software (Dedoose 2013). The research team
developed an initial coding framework through team discussion, trial, and revision based on our collective inter-
pretation of the data. We used the Dedoose software to enable blind coding and verification of code application
to check the consistency of analysis. All authors discussed coding and interpretations at regular intervals through-
out the analysis phase of the study during collaborative meetings. As well as the established initial codes, we
added further codes to the framework inductively as appropriate and then coded across all transcripts (Fereday &
Muir-Cochrane 2006).
We followed with an iterative process of analysis in which the coded data was reviewed further, specifically
investigating the key themes identified across the dataset. The team determined chosen themes through discus-
sion of the initial coding findings until a consensus was reached based upon the significance and prevalence of
each topic. We extracted all data potentially relevant to organizational, professional, and regulatory relationships.
Two researchers re-read the extracted data until satisfied that all subthemes had been identified. These two
researchers then refined the subthemes through a process of discussion, which was agreed upon by the wider
research team. We focused our analysis on the analytical framework, moving between the data and the literature
in order to refine and situate our findings (Braun & Clarke 2006, p. 84).
3. Findings
Our findings centre on three main themes: the organization as hub/core, expanded surveillance/ audit culture,
and doctors as employees. The first of these themes (organization as hub/core) focuses on the centrality of orga-
nizations to the delivery and mediation of revalidation. The second theme (expanded surveillance/audit culture)
explores the capability of organizations to oversee and control doctors. The final theme (doctors as employees)
examines the impact of revalidation on the position of doctors in organizations and of the profession more
broadly.
3.1. The organization as hub/core
The organizations that employ doctors and act as designated bodies are vital for the operationalization of revali-
dation. While revalidation as a policy is about a relationship between the regulator and its oversight of an individ-
ual doctor, in design and implementation it introduces organizations as intermediaries in that relationship in a
new way. In practice and in legislation, revalidation is mediated through and dependent upon the organizations
in which doctors work for its implementation.
The GMC is not an organizational regulator; however, the statutory responsibilities placed on organizations
by the legislation associated with revalidation, necessitated many organizations to introduce new or adapt existing
processes. This was especially true of processes for collecting and collating clinical governance information,
appraisal processes, and wider safety and quality systems:
We’ve made quite a lot of changes. We’ve put in place a different leadership structure, so we’ve got myself,
who supervises a number of Clinical Directors, who supervise a number of Clinical Leads, who supervise a
number of Consultants.1
There is clearly a role of process that has to be followed, in other words, to make sure that we offer a means
of supporting our doctors, to relicense with the GMC, we need to manage that system, and I do that on behalf
of [RO name], but every doctor’s sign off has to be discussed with [RO name]. So effectively I do all the work,
and then we have a finalizing meeting. And then also, within that role, is the management of the appraisal
system, so we need to obviously recruit and train appraisers, we need to maintain the training of appraisers,
and then we need to conduct the appraisal system in a manner that is appropriate for all permanent staff.2
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In this regard, professional regulatory intervention has driven change at organizational level with organizations
situated as the mediators of revalidation. The significance of organizations as a hub for the delivery of revalida-
tion and their position as core to its operationalization is particularly well illustrated by examples of the difficul-
ties faced by those outside or on the edges of organizational boundaries. Doctors positioned outside of
organizations, such as those working in private practice or locums, featured in participants’ narratives as the weak
link in revalidation. They were almost always identified by others or themselves as unable to access the support
provided by organizations, such as appraisal delivery, information collection, and continuing professional devel-
opment, making the revalidation process a more difficult and onerous task:
It’s getting the evidence. So it’s difficult for a doctor who is transient, moving from place to place, to get patient
feedback for instance. Or colleague feedback, because people say, well you’ve only worked here for two weeks, I
don’t really know you well enough to give you feedback. Also if a significant event arises about something, they
may well not find out that it’s happened [be]cause they may have already left or moved somewhere else.3
A locum out there is quite a risky … from a quality point of view a locum can work in one practice one day,
one practice another, so it’s quite hard to oversee their performance.4
This group of doctors were also described as those furthest outside “the net” of revalidation, which was frequently
seen as an inappropriate or insufficient approach for the performance management of those in such working con-
texts. Although a GMC policy, without the support and operationalization of employing organizations, the robust
form of regulation cannot encompass all doctors as intended.
Changes in the relationship and communication channels between the regulator and healthcare organizations
further highlighted the new significance of organizations for regulator operationalization. Each healthcare organi-
zation has, as a point of contact with the GMC, an Employer Liaison Adviser (ELA), who is the designated first
point of contact for organizations with the GMC, and from whom organizations can obtain advice and support.
This new role is identified as having improved organizations’ ability to communicate effectively with the GMC
and as an important source of informal guidance on revalidation:
We have a very good relationship with both of ours [ELAs]. We’ve got another one now, but we’ve always
got on really well with them. [RO] runs lots of things by them informally. They’re very good, they’ll get back
to you very quickly if they don’t know something. They know the answer to most questions straightaway.
We’ve found it really, really helpful in this trust … I appreciate those meetings.5
Acting as brokers of information, the ELAs are fundamental to the regulatory relationship between organizations
and the GMC, symbolizing a change in this relationship and a recognition on the part of the GMC of the central
role and significance of organizations for revalidation and the governance of doctors.
3.2. Expanded surveillance/audit culture
The changes revalidation brought to the relationship between organizations, doctors, and the regulator presented
an opportunity for organizations to expand their surveillance of doctors’ performance and an increase in audit
culture. Through compulsory appraisal, doctors are now more accountable to organizations, with non-
engagement now carrying the risk of losing licence to practice, unlike before. Revalidation is described as having
improved the collection and triangulation of performance data, which in turn has reportedly contributed to orga-
nizations’ increased ability to monitor their doctors.
The responsibility of ROs to sign off doctors as fit to practice across their whole scope of practice led many
organizations to invest in improving their performance and governance information collection and recording sys-
tems in order to provide the necessary oversight. The necessity of this oversight from the RO and the doctors’
need for performance information for their appraisal meant organizations had a new legitimacy and authority to
collect such information where before this could have been challenged:
So we gather data on their involvement in any learning, from serious incidents, complaints, that sort of thing.
We have a section called quality indicators, and in that we’d also put other stuff like if they make named
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requests a lot to pharmacy, so doctors who want to prescribe non-formulary products, that sort of thing. Any-
thing that we think is a benchmark of quality, that goes into their appraisal.6
Although on the whole, organizations collected the required information for appraisal on behalf of their doctors,
it was still the responsibility of individual doctors in most cases to obtain this information from their organiza-
tion and take this to appraisal. This meant that doctors were able to pick and choose what they presented and
revealed in an appraisal. Instances of or the possibility of doctors gaming the system by not declaring negative
information, or treating revalidation like a tick box exercise and merely jumping through the hoops, were raised.
In part to combat the tick box approach, as well as to meet the requirements of RO oversight and the need to
make an informed decision based on the whole scope of practice, organizations began to improve not only their
data collection but also the triangulation of that data and the bringing together of different information sources
to provide a more comprehensive overview of doctors practice rather than isolated information. Although full tri-
angulation has not yet been delivered in all organizations, improvements have consistently been noted, as well as
intentions to further improve the oversight organizations have over their doctors’ performance:
When a doctor has had an investigation, once that investigation is closed, we then write to them and say,
you’ve been subject to an investigation, we would like you to reflect on that in your next appraisal. And then
we use revalidation or appraisal as a way of auditing whether they are engaging with the process. So, we don’t
tell the appraiser, but if the information is not put on to the next year’s appraisal, we would then refer them
back to the GMC, or use the non-engagement, that’s how we make the doctors concerns really into
revalidation.7
So before, you know, you might get a patient complaint about somebody, there might be a clinical concern
dealt with there, something dealt with something. And it’s bits of information all over the hospital but actu-
ally nobody pulling it together, you know, nobody thinking actually that was the doctor that did … whereas
now, I think we’re picking up on that much better … And that’s been a big part of my role, I suppose, and
why I now sit in HR is to pull all that sort of stuff together. And I think a lot of this stuff, the medic stuff, has
always been dealt with by other medics and HR haven’t always been involved in it, so it’s not always been
documented very well. It’s much better documented now.8
The RO role was not the only emergent managerial function identified as having strengthened managerial over-
sight of doctors’ performance. For example, one participant identified the revalidation lead within their organiza-
tion as having a key role in triangulating information about doctors and identifying potential concerns earlier
than may previously have been the case:
I think the bit we didn’t have which has helped considerably is having a revalidation lead, so someone who’s
actually got the time to look [into] and triangulate things that may have been a bit lower on the radar. So I
think we are picking up things maybe slightly earlier than them causing, you know, being flagged up as a seri-
ous incident or whatever before that stage if there’s been some sort of complaints or some lower level incident
reporting.9
Another respondent, when referring to doctors’ work as clinical or educational supervisors for postgraduate spe-
cialty trainees, reported that systems for sharing information had improved, and this was helping to ensure that
doctors holding these roles kept up to date with their responsibilities:
I work closely with the postgrad team, in relation to education and clinical supervisor. […] So we work pretty
closely, we’ve got systems, and we’re developing, they’re developing an escalation policy, as they’ve called it,
which links to our reminder letter system. So not only are they getting me mithering them, but they’re gonna
get the postgrad team mithering them as well. Because we’ve got a lot of clinical, especially supervisors, so we
have to make sure they’re in date, to keep up that role. So that’s working, and that’s, over the last 12 months.
And the system, again, was tweaked, to allow them to use the system to demonstrate evidence for those roles,
without having to do it separately. So that’s made it easier for them, and then it’s easier for us to monitor it,
and the postgrad team have got access to the system for that section. So they can see when somebody’s had
an appraisal, but she knows that I’m chasing them, so she’ll know where we’re up to, and she’ll go, do you
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know where this person is up to, and how much chasing have you done … So I can keep her informed, espe-
cially like, the ones that have been really naughty, so I can tell her to put them on her radar as well as my
radar. So we work closely in that respect.10
Improved connections between performance systems and better processes for information sharing support orga-
nizations ability to better monitor doctors’ performance and to intervene when deemed necessary.
3.3. Doctors as employees
Changes in the relationship between organizations and professional regulation brought about by the implementa-
tion of revalidation have, as described above, shifted regulatory processes “upstream” into the organizational
sphere. Having provided an opportunity for organizations to expand their surveillance of doctors’ performance
through strengthened mechanisms of accountability and increased requirements to participate in processes of
appraisal, for example, the implementation of revalidation has impacted on the position of doctors within the
healthcare workforce.
From the perspective of those responsible for managing medical performance, the advent of revalidation has
brought doctors more into line with other healthcare professionals by bringing them under increased scrutiny
and reducing prior hierarchical differences in approaches to managing different professional groups:
It’s probably given us greater clarity, because one of the things I did notice when I had to write that policy
[for organizational revalidation systems] is that we had one about conduct for all staff, and it was very clear
at the bottom it just said, this does not apply to medics. And, I think that was because everybody knew it was
such a minefield.11
There could be a danger culturally. And it might be anecdotal and stereotypical what I’m going to say, but
that doctors might be a bit precious and might be treated a bit differently than other groups. And the revali-
dation process leaves them a bit more accountable as other professions have to be accountable, in a way that
culturally might not have been the case in the past. So doctors were always, you know, untouchable and that
kind of thing, might have been one perception in the past.12
Revalidation then is seen at least by some involved in managing doctors’ work, as having countered or negated
any lingering claims by doctors to be exempt from managerial oversight or to merit special treatment in or by
organizations. Revalidation has provided organizations with more authority over doctors and in turn has
increased doctors’ accountability to them. Many organizations have used this development to their own advan-
tage. In this vein, revalidation is seen as offering a means by which doctors can be compelled to participate in
organizational management processes, serving to draw them into a “governed system” in new ways:
One of the things I think has been really helpful is the being able to articulate to doctors that actually being
engaged with your work is the duty and I think that’s one of the things that is a lifeline actually. So, the sort
of, I couldn’t care less about the organization, I just care about my patient, trying to explain that that isn’t
engagement. I’m not going to meet my line manager because I’m [a] doctor, I’m not prepared to hear that. It
is possible to say to people, actually that, you know, engagement is about actually being part of a governed
system, and I think that does help. I don’t think people like it but it is not optional.13
Prior differences in approaches to managing performance between professions were the result of historical
assumptions that medical professionalism and individual self-regulation would ensure that doctors conformed to
high standards of care and behaviour:
…I think in general people still regard their professional duty as something they take quite seriously, and the
whole principle about being a professional is about self-regulation and making sure your standards are of the
highest and making sure you do keep up to date and you do operate with integrity and honesty and all the
things that make good medical practice. […] It was that presumed professionalism in a way that was the old
way, so what we’re now saying is we need a bit of evidence behind that before we can make presumptions.14
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One RO suggested that the requirement that doctors seek colleague feedback as part of revalidation may be con-
tributing to a reduction in the perceived sense of independence or even superiority from doctors, given they may
now be subject to critique:
People’s behaviour is definitely improving […] I think people become more humble, in a way, so that stub-
bornness, big-headedness, that type of thing actually becomes less of an issue because people know that you
can’t just behave in a randomly whatever way assuming I’m the authoritarian person, because people will
actually feel … you are working with these guys where you’re going to ask them later on, tell me about me.15
While some framed the impact of revalidation as being to diminish medics’ status and autonomy, others sug-
gested that the personal responsibility placed upon individual doctors to participate in the process and to collect
the requisite supporting information means that significant scope for action, and therefore perhaps autonomy,
remains with the doctors themselves:
It’s kind of giving that responsibility back [to] the professionals. As part of their revalidation, they’re now
expected to demonstrate, you know, how they are meeting their relevant guidelines at the moment. And as
part of that, they will look to what data’s available locally in terms of their supervision or their ward-based
information. But as you say, they also will come to us as well to help include that.16
However, elsewhere it was clear that while responsibility for meeting the requirements of revalidation as a regula-
tory process remains with the doctor, the degree to which this responsibility is exercised independently is limited.
Rather some organizations monitor doctors’ compliance with the requirements, leaving it as their responsibility
to submit supporting information to appraisal but intervening if this is not done:
So if you’ve had a complaint for example, it’s expected, we don’t in this trust put that onto the form. I know
that some trusts would … somebody would populate your, you know, ePortfolio with that. But we would
expect the person to declare that, so if there was a chance that something, bit of information that we are hold-
ing – which is all high level information – and there’s nothing on the persons appraisal about that, then I
would go back to the person to say, look, I know you were involved in a serious incident last year; this must
have had a high impact on you, why are we not seeing anything on your appraisal, for example.17
In this instance, doctors’ independence in selecting information to discuss in their appraisal is limited by over-
sight from senior managers. Doctors are required to submit any complaints they have received about their prac-
tice as part of their appraisal portfolio each year, so this example shows organizational management processes
ensuring that doctors are compliant with the process. However, it also belies the notion that placing responsibility
for collecting supporting information with doctors may somehow support or protect their autonomy within this
process. Rather, doctors are made accountable for their compliance with the requirements of the system, with
organizational follow-up and intervention if they do not conform.
Managers described their strengthened ability to manage doctors positively. One gave examples of instances
in which potential problems with doctors’ behavior had been identified and acted upon, and that using colleague
feedback and appraisal had enabled them to support the doctor to amend his approach and ultimately remain
with the organization. Importantly, one managerial approach in this case had been to notify the doctor that infor-
mation about the concerns with their performance would be passed onto new employers should he leave the
organization:
We had a fairly newly appointed consultant … whose multi-professional team was saying that they found
him bossy and overbearing and not good at listening […] He wouldn’t hear it, wouldn’t hear it, wouldn’t hear
it. He was quite argumentative with his line manager but it was then … when his appraisal came round it
was possible to have a discussion with him that actually he hadn’t been reflective at all in his appraisal about
almost anything. […] it was possible to meet with him and just say, look, you know, we need to get on top of
this before you … or if you’re going to move we would … your transfer form, we would have to say that
we’re in the midst of trying to help with this. So that, I think, helped him steady up and we were able to say
that we would give him positive support, whether he stayed or whether he went. We … put a plan in place
describing much more clearly the desired and undesired behaviors and he stayed.18
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For many in managerial positions, therefore, the advent of revalidation is seen has having provided impetus for
improved information sharing, extended management processes, and, overall, has increased oversight of the med-
ical profession working within an organization. Moreover, such increased oversight has contributed to an appar-
ent further degradation of doctors’ professional autonomy, tying them more closely to organizations’ managerial
processes, as the regulatory requirements placed upon doctors by revalidation are fulfilled through systems largely
operating within and mediated by those organizations.
4. Discussion
In this paper we have explored how the implementation of revalidation has impacted on the regulatory relation-
ships between the GMC, healthcare organizations, and doctors. Revalidation is but one of a number of reforms,
and its implementation has taken place against the wider backdrop of ongoing changes and parallel reforms that
have impacted on medical autonomy in different ways (Scott et al. 2000; McGivern & Fischer 2010; Adams
2017). The reduction in medical autonomy attributed to these changes has been argued as necessary and timely
(Chamberlain 2014; Saks 2014), although some would argue that it represents an unwarranted expansion of regu-
latory control (Williams et al. 2014). As a component of regulation, revalidation is an important innovation when
contrasted both with systems of medical regulation internationally and with the regulation of other health profes-
sions in the UK (Spendlove 2013; Archer et al. 2017). Instead of doctors interacting directly (and relatively rarely)
with the professional regulator, revalidation requires that appraisal and other information about performance
instead be collected and considered at the organizational level, under the auspices of the RO.
The three themes from our findings, the organization as hub/core, expanded surveillance/audit culture, and
doctors as employees, are interdependent. The working of each theme is dependent on the others, and it is as a
result of the combination of all three areas that revalidation has shifted the regulatory process upstream and into
the organizational sphere. Through revalidation, the GMC has delegated some responsibility for overseeing per-
formance to organizations via ROs and in doing so has passed on most of the responsibility and much of the
cost. Healthcare organizations are being made accountable for overseeing doctors in a new way, which has
extended regulatory surveillance and oversight at a local level. For organizations, the implications of this
upstream shift have centred predominantly on their increasingly important intermediary role in the relationship
between the GMC and doctors. In operationalizing revalidation, organizations have to adhere to requirements set
out by the GMC and through legislation, meaning that in many ways they themselves have experienced a form of
regulation. Meeting these requirements frequently meant substantial changes to organizations’ governance prac-
tices and costly investment in infrastructure. While making organizations more answerable to the GMC and pro-
viding a new workload, the expanded surveillance of performance and the strengthened mechanisms of
accountability brought by revalidation have provided them with new authority and leverage over doctors. Organi-
zations are able to use revalidation to bring doctors more into the organizational sphere and to bring about
adherence to their own agendas. Changes to the relationships organizations had with both doctors and the regu-
lator fit well with the governmentality thesis, although at an organizational rather than a professional level in this
instance. In enacting the GMC’s guidelines, organizations self-regulate but in turn use this to their own advantage
to increase control of their doctors. The expectations of the GMC for doctors have been taken on by healthcare
organizations who accepted the required self-adaption to ensure these could be met.
As a consequence of the increased governance occurring at an organizational level, the position of doctors within
the healthcare workforce has also been impacted. The need for doctors to revalidate and their reliance on organiza-
tions to facilitate that process has thus enabled organizations to legitimately increase their oversight of doctors and
bring them into line with organizational agendas and priorities. The increased reliance of doctors on organizations for
support to enact the revalidation policy is well evidenced by the difficulties experienced by those working outside orga-
nizational boundaries, doctors who are not employees, or who have a relatively transient or distant relationship to
their employing organization. Because of the lack of organizational support available to such individuals, the regulatory
relationship became increasingly problematic. The implementation of revalidation has highlighted shortcomings in the
governance of this category of doctors, which remains unresolved. However, such concerns about the effectiveness of
regulation for doctors outside organizational boundaries have been recognized by policymakers (Pearson 2017). Fur-
ther changes to this area of regulation are likely as a result, highlighting the need for further research.
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In addition to tying doctors more closely into organizations’ managerial processes, revalidation has also
reduced prior hierarchical differences in approaches to managing different professional groups, positioning doc-
tors as more like other employees. The new accountability doctors experience was framed, in particular, by orga-
nizations, the GMC, and doctors in roles contributing to the implementation of revalidation, as part of their
professional obligations. This accountability has been positioned as existing alongside and perhaps in contrast to
an apparent degradation of doctors’ professional autonomy and power. Although to some degree the RO role can
be seen as a form of restratification overall, there has been some loss of professional autonomy and hierarchical
power, both collectively and individually, as a result of revalidation (Bryce et al. 2018). Existing research has
begun to consider possible hybrid roles and creative compliance, both more generally and as developed as a result
of revalidation (Noordegraaf 2016; Bryce et al. 2018; Spendlove 2018). This work has identified an increase in
hybrid roles within the professions (including medicine) and as a result professional work has become more
“linked to outside worlds, especially organizational contexts,” thus becoming more accountable to them
(Noordegraaf 2016, p. 785; Evetts 2011). What professionalism means is understood as an increasingly unstable
category that is less isolated than before and requires more active legitimization. The findings of this paper echo
this. Meeting the requirements of revalidation and being a more integral part of the organization has been posi-
tioned as a part of doctors’ roles and as central to a new more modern conceptualization of professionalism, both
by those of the profession and those managing doctors. In the case of revalidation, the regulatory elements of the
triumvirate relationships under investigation add a new driver in the development of what constitutes profession-
alism. Further investigation in these areas would be beneficial in light of the ongoing changes to medical auton-
omy, regulation, and the understanding of professionalism identified in this paper.
The findings of the research have some implications for our understanding of professional regulation internation-
ally. Existing research looking at the different systems of continued competency for doctors has found that effective-
ness is dependent upon the degree to which these systems are accepted and engaged with by the profession (Sehlbach
et al. 2018a,b). This study has shown that the way in which doctors understand and conceptualize professionalism is
important for how they accept changes to their accountability and regulation. Given the international nature of the
medical workforce, and varied cultural conceptualizations of professionalism, considering the acceptance and success
of such regulatory changes across and for those crossing national borders also warrants further research.
5. Conclusions
Revalidation was introduced with the aim of improving patient safety and the quality of medical care, however, it
is too early to be able to determine what impact revalidation has had on safety and quality. Overall, the discourse
used to articulate and enact the changes involved in implementing revalidation is primarily one of accountability,
essentially concerned with to whom doctors, as a profession, should answer and to what degree.
Accountability is in many ways the key point of convergence to determine the impact of revalidation’s on the
triumvirate relationship investigated. Changes to each party’s domain of accountability has altered the way these
three stakeholders – the regulator, the medical profession, and employer organizations – relate to and interact
with each other and the way in which the medical profession is governed. Organizations have become intermedi-
aries in the relationship between the GMC and doctors, enacting regulatory processes on its behalf and extending
regulatory surveillance and oversight at local level. As the importance of organizational ties strengthened, doctor’s
autonomy was reduced and the extent of organizational oversight increased.
What it means to be a doctor has been reframed through revalidation in ways that strengthen organizational
accountabilities and make the organizational setting central to systems of oversight, changes compatible with
ideas of governmentality.
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Notes
1 Interview 21 – RO.
2 Interview 37 – Associate MD for Revalidation.
3 Interview 73 – LMC CEO.
4 Interview 59 – Senior Project Officer.
5 Interview 52 – Reval Manager.
6 Interview 52 – Reval Manager.
7 Interview 76 – RO.
8 Interview 52 – Reval Manager.
9 Interview 40 – AMD and Revalidation Lead.
10 Interview 44 – Reval Manager.
11 Interview 84 – RO.
12 Interview 22 – Director of Professional Practice, Safety and Quality.
13 Interview 31 – RO.
14 Interview 41 – RO.
15 Interview 54 – RO.
16 Interview 56 – Complaints Manager.
17 Interview 35 – Previous Associate MD.
18 Interview 31 – RO.
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